1. The combined serum levels ofmiR-375and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer
   Sven Wach et al, 2015, International Journal of Cancer CrossRef
2. Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression
   Julia M.A. Pickl et al, 2016, Oncotarget CrossRef
3. The PCAT3/PCAT9-miR-203-SNAI2 axis functions as a key mediator for prostate tumor growth and progression
   Fangfang Tao et al, 2018, Oncotarget CrossRef
4. A review on the role of PCA3 lncRNA in carcinogenesis with an especial focus on prostate cancer
   Soudeh Ghafouri-Fard et al, 2022, Pathology - Research and Practice CrossRef
5. Noncoding RNAs as Novel Biomarkers in Prostate Cancer
   C. G. H. Rönnau et al, 2014, BioMed Research International CrossRef
6. Interplay between the androgen receptor signaling axis and microRNAs in prostate cancer
   Rayzel C Fernandes et al, 2019, Endocrine-Related Cancer CrossRef
7. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells
   Karla Kohan-Ivani et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
8. Exosomes as divine messengers: are they the Hermes of modern molecular oncology?
   C Braicu et al, 2015, Cell Death & Differentiation CrossRef
9. The potential of sertoli cells (SCs) derived exosomes and its therapeutic efficacy in male reproductive disorders
   Narjes Amiri et al, 2023, Life Sciences CrossRef
10. Coordinated AR and microRNA regulation in prostate cancer
    Ieva Eringyte et al, 2020, Asian Journal of Urology CrossRef
11. Androgen-Regulated microRNAs (AndroMiRs) as Novel Players in Adipogenesis
    Julia Jansen et al, 2019, International Journal of Molecular Sciences CrossRef